Rochester, NY 8/11/2009 2:54:25 PM
After Hours - Johnson & Johnson, JNJ - Elan to change J&J deal to prevent legal complications
Johnson & Johnson
Elan one of the leading pharmaceutical group, may change elements of its recent partnership agreement with industry giant Johnson & Johnson (J&J) in order to prevent legal complications that may affect an existing collaboration with Biogen Idec.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Elan went to court last week to prevent Biogen, with whom it is engaged in a 50-50 joint venture to develop a treatment for multiple sclerosis, from invoking terms of the J&J deal as grounds to change the current Elan-Biogen arrangement.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
